Free tool
Healthcare stocks
We cover 92 companies in the Healthcare sector. The median market value in the group is $60.36M. Across the group, the median move over the past trading day is +0.07%. 82% of the 92 with a 200-day average trade above it. Price change over the past year runs from −41.6% to +264.0% across the middle 80 percent of the group, with a median of +14.3%. Across the group, 2 companies currently carry a tier A volume signal.
Other lists in this group
Table
92 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| MRCK34.SA | Merck & Co., Inc. | 101.37 BRL | +20.05% | +39.73% | +81.07% |
| MRK | Merck & Co., Inc. | $153.10 | +16.14% | +44.89% | +86.85% |
| 6MK.DE | Merck & Co., Inc. | 131.98 EUR | +18.20% | +47.72% | +90.43% |
| AMGN34.SA | Amgen Inc. | 81.32 BRL | +13.94% | +69.69% | +47.79% |
| TMO | Thermo Fisher Scientific Inc. | $633.71 | +9.94% | +7.06% | +30.17% |
| TMOS34.SA | Thermo Fisher Scientific Inc. | 67.15 BRL | +9.49% | −0.22% | +22.22% |
| AVTR | Avantor, Inc. | $14.50 | +16.75% | +26.53% | +9.93% |
| BIO-B | Bio-Rad Laboratories, Inc. | $365.08 | +18.01% | +17.50% | +47.78% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $84.84 | +1.17% | +81.55% | +179.08% |
| RHC.AX | Ramsay Health Care Limited | 50.09 AUD | +13.35% | +46.21% | +50.95% |
| TXG | 10x Genomics, Inc. | $64.26 | +36.58% | +286.64% | +358.35% |
| GETI-B.ST | Getinge AB (publ) | 246.60 SEK | +4.45% | +16.11% | +21.94% |
| HLUN-A.CO | H. Lundbeck A/S | 41.70 DKK | +15.51% | +16.60% | +29.36% |
| CNTA | Centessa Pharmaceuticals plc | $40.50 | 0.00% | +70.96% | +143.24% |
| HAE | Haemonetics Corporation | $106.60 | +29.15% | +33.28% | +93.71% |
| HTFL | Heartflow, Inc. | $48.94 | +91.25% | +68.93% | +40.79% |
| ITGR | Integer Holdings Corporation | $125.19 | +24.72% | +63.05% | +15.84% |
| ANN.AX | Ansell Limited | 40.99 AUD | +24.06% | +17.78% | +22.15% |
| AMLX | Amylyx Pharmaceuticals, Inc. | $37.08 | +89.67% | +224.69% | +292.38% |
| IDYA | IDEAYA Biosciences, Inc. | $41.58 | +14.99% | +22.84% | +66.32% |
| ABCL | AbCellera Biologics Inc. | $12.24 | +131.38% | +256.85% | +181.38% |
| CPRX | Catalyst Pharmaceuticals Inc | $31.49 | 0.00% | +36.03% | +55.97% |
| OGN | Organon & Co. | $13.77 | +1.85% | +90.95% | +50.67% |
| A2LC34.SA | Alcon Inc. | 38.00 BRL | +11.50% | −13.23% | −12.15% |
| PLSE | Pulse Biosciences, Inc. | $48.10 | +35.61% | +259.22% | +203.47% |
| MRVI | Maravai LifeSciences Holdings, Inc. | $8.90 | +29.74% | +161.76% | +281.97% |
| AVAH | Aveanna Healthcare Holdings Inc. | $13.62 | +37.71% | +68.56% | +73.50% |
| ZLAB | Zai Lab Limited | $26.03 | +39.80% | +50.20% | −20.06% |
| CDNA | CareDx, Inc. | $50.96 | +42.55% | +166.25% | +283.45% |
| BV3.DE | Bavarian Nordic A/S | 28.92 EUR | +20.90% | +11.88% | +14.31% |
| BAVA.CO | Bavarian Nordic A/S | 215.80 DKK | +20.63% | +11.93% | −8.79% |
| ATRC | AtriCure, Inc. | $48.17 | +21.18% | +22.66% | +29.14% |
| ONT.L | Oxford Nanopore Technologies plc | 178.60 GBP | +56.80% | +39.53% | −1.27% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| XNCR | Xencor, Inc. Common Stock | $28.44 | +42.41% | +90.62% | +254.61% |
| SRPT | Sarepta Therapeutics, Inc. | $19.46 | +26.12% | −8.68% | +7.69% |
| 366A.T | WELLNESS COMMUNICATIONS CORPORA | 1,190.00 JPY | +17.01% | +12.00% | −22.58% |
| ONCO.ST | Oncopeptides AB (publ) | 2.08 SEK | +31.19% | −57.37% | −58.44% |
| APLM | Apollomics, Inc. | $26.20 | +43.80% | +35.75% | +320.55% |
| KOO.L | Kooth plc | 167.00 GBP | +10.23% | +45.22% | +6.03% |
| INCR | InterCure Ltd. | $5.95 | +546.74% | +477.67% | +265.03% |
| CINPHA.ST | Cinclus Pharma Holding AB (publ) | 14.00 SEK | +17.85% | −27.08% | −10.26% |
| 4512.T | Wakamoto Pharmaceutical Co.,Ltd. | 312.00 JPY | +16.42% | +9.78% | +2.30% |
| INMB | INmune Bio Inc. | $2.45 | +42.98% | +58.77% | +19.56% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 18.75 SEK | +19.05% | −1.32% | −30.04% |
| SAR.L | Sareum Holdings plc | 35.38 GBP | +68.48% | +108.12% | +76.90% |
| 4584.T | Kidswell Bio Corporation | 181.00 JPY | +29.29% | −14.62% | −29.02% |
| NTRB | Nutriband Inc. | $4.50 | +52.28% | +1.58% | −29.80% |
| OHGR.L | One Health Group Plc | 292.50 GBP | +10.38% | +16.53% | +17.03% |
| HYPD | Hyperion DeFi, Inc. | $3.39 | +40.08% | −5.31% | −50.87% |
| 9218.T | Mental Health Technologies Co.,Ltd. | 793.00 JPY | +7.02% | −2.46% | −5.18% |
| ENP.AX | Entropy Neurodynamics Limited | 0.04 AUD | +17.14% | +28.12% | +10.81% |
| HOWL | Werewolf Therapeutics, Inc. | $0.99 | +120.22% | +53.30% | −25.65% |
| NSRX | Nasus Pharma Ltd. | $4.05 | +33.66% | −46.36% | −49.75% |
| 9340.T | ASO International, Inc. | 770.00 JPY | +5.48% | +5.91% | +8.04% |
| 4890.T | Tsubota Laboratory Incorporated | 290.00 JPY | +20.33% | −11.31% | −20.77% |
| 4583.T | Chiome Bioscience Inc. | 85.00 JPY | +26.87% | −20.56% | −37.96% |
| AREC.L | Arecor Therapeutics plc | 66.00 GBP | +3.94% | −22.35% | +3.94% |
| HBIO | Harvard Bioscience, Inc. | $7.65 | +29.22% | +17.69% | +44.34% |
| SIGHT.PA | GenSight Biologics S.A. | 0.13 EUR | +53.44% | +11.58% | −21.96% |
| 4591.T | Ribomic Inc. | 93.00 JPY | +32.86% | +19.23% | −13.08% |
| CONTX.OL | ContextVision AB (publ) | 4.22 NOK | +24.12% | +1.69% | −4.95% |
| RENX.L | Renalytix Plc | 4.25 GBP | +60.38% | −27.97% | −27.35% |
| RUA.L | RUA Life Sciences plc | 28.00 GBP | +12.01% | +103.66% | +146.18% |
| 4884.T | Kringle Pharma, Inc. | 453.00 JPY | +42.90% | +15.56% | −7.36% |
| EZZ.AX | EZZ Life Science Holdings Limited | 0.64 AUD | +37.63% | −55.79% | −72.54% |
| PMI | Picard Medical, Inc. | $9.80 | +122.73% | +438.46% | +113.51% |
| 5619.T | MRSO INC | 905.00 JPY | +6.97% | +2.26% | −16.90% |
| VYNE | VYNE Therapeutics Inc | $28.56 | +3080.40% | +4824.14% | +8660.74% |
| 7813.T | Platz Co., Ltd. | 877.00 JPY | +11.01% | +9.76% | +14.19% |
| LEXX | Lexaria Bioscience Corp. | $11.04 | +36.30% | +1588.07% | +1146.05% |
| CMMB | Chemomab Therapeutics Ltd. | $2.59 | +81.12% | +44.69% | −25.57% |
| BTC.AX | BTC Health Limited | 0.06 AUD | +15.09% | −1.61% | −6.15% |
| HSCS | HeartSciences Inc. | $2.99 | +32.30% | −4.78% | −11.54% |
| CRTX.L | CRISM Therapeutics Corporation | 11.50 GBP | +21.05% | +15.00% | +9.52% |
| GENI.L | GENinCode Plc | 1.20 GBP | +50.00% | −50.00% | −14.29% |
| AZTR | Azitra, Inc. | $0.17 | +33.00% | −38.03% | −83.21% |
| 7090.T | Ligua Inc. | 946.00 JPY | +17.52% | +1.28% | −13.45% |
| FBLG | FibroBiologics, Inc. | $1.41 | +116.92% | −70.62% | −88.25% |
| XBIO | Xenetic Biosciences, Inc. | $3.86 | +54.40% | +79.53% | +35.92% |
| SKYE | Skye Bioscience, Inc. | $2.02 | +228.46% | +130.07% | −41.62% |
| CURX | Curanex Pharmaceuticals Inc | $4.60 | +2223.23% | +1150.00% | −1.29% |
| IXC.AX | Invex Therapeutics Ltd | 0.13 AUD | +18.18% | +4.00% | +30.00% |
| CNSL.L | Cambridge Nutritional Sciences plc | 1.90 GBP | +8.57% | −2.56% | −41.54% |
| FLUI.ST | Fluicell AB (publ) | 38.70 SEK | +22.86% | +287.00% | +287.00% |
| BMRA | Biomerica, Inc. | $1.69 | +5.62% | −33.21% | −46.35% |
| GLMD | Galmed Pharmaceuticals Ltd. | $4.33 | +710.86% | +426.12% | +211.51% |
| FDBK.L | Feedback plc | 7.00 GBP | +15.70% | −34.88% | −47.17% |
| BIAF | bioAffinity Technologies, Inc. | $5.09 | +710.51% | +317.21% | −31.59% |
| PPCB | Propanc Biopharma, Inc. | $1.07 | −11.57% | −92.51% | −98.54% |
| SCNI | Scinai Immunotherapeutics Ltd. | $2.87 | +987.12% | +293.15% | +93.92% |
| APM | Aptorum Group Ltd | $8.41 | −6.45% | +685.98% | +273.78% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.